← Open Payments lookup

NICHOLE FLEMING: Open Payments

NPI 1871998518 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,249 in 64 payments from 11 companies in 2025. Trend: 2023 $1,383 · 2024 $963 · 2025 $1,249

Food & beverage: $1,249
CompanyPaymentsAmount
PFIZER INC.23$604
Celltrion USA Inc.20$202
Lilly USA, LLC3$74
Janssen Biotech, Inc.4$71
Ardelyx, Inc.3$61
GENZYME CORPORATION2$54
Salix Pharmaceuticals, a division of Bausch Health US, LLC3$52
Ipsen Biopharmaceuticals, Inc2$50
Aimmune Therapeutics, Inc.2$30
ABBVIE INC.1$30

Products named: VELSIPITY, VEGZELMA, OMVOH, TREMFYA, IBSRELA, DUPIXENT, XIFAXAN, IQIRVO.

Industry payments across TX — which companies pay providers there.